Medication Guide App

Label Changes for:

Bicnu (carmustine) for injection

March 2011

Changes have been made to the PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011

 

 

PRECAUTIONS

Drug Interactions
  • Greater myelotoxicity (e.g., leukopenia and neutropenia) have been reported when carmustine was combined with cimetidine.

ADVERSE REACTIONS

Hematologic Toxicity
  • Greater myelotoxicity (e.g., leukopenia and neutropenia) has been reported when carmustine was combined with cimetidine.
Hide
(web5)